Effect of naftidrofuryl oxalate (LS-121) on experimental amnesia model in rats

Tsutomu Kameyama, Toshitaka Nabeshima, Akira Katoh, Shin ichi Ogawa

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Effects of naftidrofuryl oxalate (LS-121) on experimental amnesia models, which were induced by cycloheximide (CXM), scopolamine (SLOP) and basal-forebrain (BF) lesion, were investigated using the step-through passive avoidance response in rats. In the retention test, a cut-off time of 600 sec was employed for the measurement of step-through latency (STL). The animals, that showed over 300 sec of STL was regarded as having the criterion of memory retention (% of retention). Increase in both parameters of STL and % of retention was regarded to indicate that the drug was able to improve the amnesia. If only one of the two parameters was increased, we considered that the drug had a tendency to improve the amnesia. Pretraining, post-training and pre-retention treatment of LS-121 (25 mg/kg) improved CXM-and SLOP-induced amnesia. Post-training treatment of LS-121 (25 mg/kg) showed a tendency to improve the BF lesion-induced amnesia. These results suggest that the antiamnesic action of LS-121 may be produced through an activation of the acetylcholinergic neuronal system. Since it improved the amnesia when administered in the pre-retention test, there is a possibility that LS-121 has not only a protective effect, but also a therapeutic effect. Furthermore, it is suggested that LS-121 may also have a therapeutic effect on Alzheimer's disease, since it showed a tendency to improve the BF lesion-induced amnesia.

Original languageEnglish
Pages (from-to)241-250
Number of pages10
JournalFolia Pharmacologica Japonica
Volume92
Issue number4
DOIs
Publication statusPublished - 01-01-1988

Fingerprint

Nafronyl
Amnesia
Oxalates
Theoretical Models
Therapeutic Uses
Cycloheximide
Scopolamine Hydrobromide
Pharmaceutical Preparations
Alzheimer Disease
Retention (Psychology)

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Kameyama, Tsutomu ; Nabeshima, Toshitaka ; Katoh, Akira ; Ogawa, Shin ichi. / Effect of naftidrofuryl oxalate (LS-121) on experimental amnesia model in rats. In: Folia Pharmacologica Japonica. 1988 ; Vol. 92, No. 4. pp. 241-250.
@article{6e4b860da92c4b008dd3d924cca3fc9e,
title = "Effect of naftidrofuryl oxalate (LS-121) on experimental amnesia model in rats",
abstract = "Effects of naftidrofuryl oxalate (LS-121) on experimental amnesia models, which were induced by cycloheximide (CXM), scopolamine (SLOP) and basal-forebrain (BF) lesion, were investigated using the step-through passive avoidance response in rats. In the retention test, a cut-off time of 600 sec was employed for the measurement of step-through latency (STL). The animals, that showed over 300 sec of STL was regarded as having the criterion of memory retention ({\%} of retention). Increase in both parameters of STL and {\%} of retention was regarded to indicate that the drug was able to improve the amnesia. If only one of the two parameters was increased, we considered that the drug had a tendency to improve the amnesia. Pretraining, post-training and pre-retention treatment of LS-121 (25 mg/kg) improved CXM-and SLOP-induced amnesia. Post-training treatment of LS-121 (25 mg/kg) showed a tendency to improve the BF lesion-induced amnesia. These results suggest that the antiamnesic action of LS-121 may be produced through an activation of the acetylcholinergic neuronal system. Since it improved the amnesia when administered in the pre-retention test, there is a possibility that LS-121 has not only a protective effect, but also a therapeutic effect. Furthermore, it is suggested that LS-121 may also have a therapeutic effect on Alzheimer's disease, since it showed a tendency to improve the BF lesion-induced amnesia.",
author = "Tsutomu Kameyama and Toshitaka Nabeshima and Akira Katoh and Ogawa, {Shin ichi}",
year = "1988",
month = "1",
day = "1",
doi = "10.1254/fpj.92.241",
language = "English",
volume = "92",
pages = "241--250",
journal = "Folia Pharmacologica Japonica",
issn = "0015-5691",
publisher = "Japanese Pharmacological Society",
number = "4",

}

Effect of naftidrofuryl oxalate (LS-121) on experimental amnesia model in rats. / Kameyama, Tsutomu; Nabeshima, Toshitaka; Katoh, Akira; Ogawa, Shin ichi.

In: Folia Pharmacologica Japonica, Vol. 92, No. 4, 01.01.1988, p. 241-250.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of naftidrofuryl oxalate (LS-121) on experimental amnesia model in rats

AU - Kameyama, Tsutomu

AU - Nabeshima, Toshitaka

AU - Katoh, Akira

AU - Ogawa, Shin ichi

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Effects of naftidrofuryl oxalate (LS-121) on experimental amnesia models, which were induced by cycloheximide (CXM), scopolamine (SLOP) and basal-forebrain (BF) lesion, were investigated using the step-through passive avoidance response in rats. In the retention test, a cut-off time of 600 sec was employed for the measurement of step-through latency (STL). The animals, that showed over 300 sec of STL was regarded as having the criterion of memory retention (% of retention). Increase in both parameters of STL and % of retention was regarded to indicate that the drug was able to improve the amnesia. If only one of the two parameters was increased, we considered that the drug had a tendency to improve the amnesia. Pretraining, post-training and pre-retention treatment of LS-121 (25 mg/kg) improved CXM-and SLOP-induced amnesia. Post-training treatment of LS-121 (25 mg/kg) showed a tendency to improve the BF lesion-induced amnesia. These results suggest that the antiamnesic action of LS-121 may be produced through an activation of the acetylcholinergic neuronal system. Since it improved the amnesia when administered in the pre-retention test, there is a possibility that LS-121 has not only a protective effect, but also a therapeutic effect. Furthermore, it is suggested that LS-121 may also have a therapeutic effect on Alzheimer's disease, since it showed a tendency to improve the BF lesion-induced amnesia.

AB - Effects of naftidrofuryl oxalate (LS-121) on experimental amnesia models, which were induced by cycloheximide (CXM), scopolamine (SLOP) and basal-forebrain (BF) lesion, were investigated using the step-through passive avoidance response in rats. In the retention test, a cut-off time of 600 sec was employed for the measurement of step-through latency (STL). The animals, that showed over 300 sec of STL was regarded as having the criterion of memory retention (% of retention). Increase in both parameters of STL and % of retention was regarded to indicate that the drug was able to improve the amnesia. If only one of the two parameters was increased, we considered that the drug had a tendency to improve the amnesia. Pretraining, post-training and pre-retention treatment of LS-121 (25 mg/kg) improved CXM-and SLOP-induced amnesia. Post-training treatment of LS-121 (25 mg/kg) showed a tendency to improve the BF lesion-induced amnesia. These results suggest that the antiamnesic action of LS-121 may be produced through an activation of the acetylcholinergic neuronal system. Since it improved the amnesia when administered in the pre-retention test, there is a possibility that LS-121 has not only a protective effect, but also a therapeutic effect. Furthermore, it is suggested that LS-121 may also have a therapeutic effect on Alzheimer's disease, since it showed a tendency to improve the BF lesion-induced amnesia.

UR - http://www.scopus.com/inward/record.url?scp=0023681220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023681220&partnerID=8YFLogxK

U2 - 10.1254/fpj.92.241

DO - 10.1254/fpj.92.241

M3 - Article

C2 - 3243510

AN - SCOPUS:0023681220

VL - 92

SP - 241

EP - 250

JO - Folia Pharmacologica Japonica

JF - Folia Pharmacologica Japonica

SN - 0015-5691

IS - 4

ER -